Pipeline Previews

By No Comments
FDA Approval of CIP-ISOTRETINOIN Cipher Pharmaceuticals Inc. has announced that the FDA has approved AbsoricaTM, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe…
Read More

Clinical Trial Review

By No Comments
ROSACEA A Single Site Evaluation of the Effect of Topical Application of Aminocaproic Acid (ACA) to Inhibit Kallikrein 5 Serine Protease Activity and Production of LL-37 Cathelicidin Peptide, Biochemical Markers…
Read More